Document:

Arbinet-thexchange, Inc. Form of Performance Share Award Agreement

 EXHIBIT 10.1  
 ARBINET-THEXCHANGE, INC. 
 Performance Share Award Agreement 
 Granted Under 2004 Stock Incentive Plan 
 AGREEMENT made this              day of                  2006 between
Arbinet-thexchange, Inc., a Delaware corporation (the “Company”), and                          (the
“Participant”). 
 For valuable consideration, receipt of which is acknowledged, the parties hereto agree as follows: 

1. Grant of Award. The Company hereby agrees to award (the “Award”) to the Participant shares of common stock, $0.001 par value, of
the Company (“Common Stock”), the number of which shall be determined pursuant to, and subject to the attainment of performance goals set forth in Exhibit A (the “Performance Goals”). The Award is granted pursuant to, and is
subject to the terms and conditions of, this Agreement and the provisions of the Company’s 2004 Stock Incentive Plan (the “Plan”). All capitalized terms not otherwise defined herein shall have the meaning ascribed in the Plan.

 2. Acceptance of Award. The Participant hereby acknowledges the receipt of the Award and understands the Award represents a
commitment of the Company to issue shares of Common Stock, subject to attainment of the Performance Goals. 
 3. Satisfaction of
Conditions. The Compensation Committee (the “Committee”) shall certify at its first meeting after each of December 31, 2007 and December 31, 2008 (each a “Measurement Date”), which shall in no event be later than
two and one-half months after the end of the Measurement Date, whether and the extent to which the Performance Goals have been met on such Measurement Date and shall direct the Company to issue the corresponding number of shares of Common Stock to
the Participant, provided that the Participant is employed or 

 
otherwise affiliated with the Company on the date of Committee certification. The number of shares of Common Stock to be issued to the Participant with
respect to the 2007 Measurement Date is determined by the Company’s attainment of Performance Goals for the performance period beginning January 1, 2006 through December 31, 2007. The number of shares of Common Stock to be issued to
the Participant with respect to the 2008 Measurement Date is determined by the Company’s attainment of the Performance Goals for the performance period beginning January 1, 2006 through December 31, 2008, reduced by the number of
shares of Common Stock already issued to the Participant with respect to the 2007 Measurement Date. Any shares of Common Stock not earned by the first Committee meeting in 2009 shall not be issued to the Participant. 
 4. Termination of Employment/Service Relationship. If the Participant ceases to have any employment or other service relationship with the Company
either as an employee, director or consultant for any reason prior to the dates of Committee certification, no Common Stock shall be issued. The Participant’s eligibility to receive issued shares of Common Stock is conditioned on the
Participant’s continuous employment or other service relationship with the Company through and on the dates of Committee certification and attainment of Performance Goals. 
 5. Change in Control. In the event of a Change in Control of the Company prior to the first Committee meeting in 2009, immediately prior to the
consummation of the Change in Control, the Participant shall be issued a number of shares of Common Stock equal to the number of Target Shares, reduced by the number of shares of Common Stock previously issued to the Participant under this
Agreement. 

 For purposes of this Agreement, a “Change in Control” of the Company shall mean a change in
ownership or control of the Company effected through any of the following transactions: 
 (i) a merger, consolidation or
other reorganization approved by the Company’s stockholders, unless securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter
beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Company’s outstanding voting securities immediately prior to such transaction, or 
 (ii) a stockholder-approved sale, transfer or other disposition of all or substantially all of the Company’s assets, or 

(iii) the closing of any transaction or series of related transactions pursuant to which any person or any group of persons comprising
a “group” within the meaning of Rule 13d-5(b)(1) of the Securities Exchange Act of 1934, as amended (the “1934 Act”) (other than the Company or a person that, prior to such transaction or series of related transactions, directly
or indirectly controls, is controlled by or is under common control with, the Company) becomes directly or indirectly the beneficial owner (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing (or convertible into or
exercisable for securities possessing) more than fifty percent (50%) of the total combined voting power of the Company’s securities (as measured in terms of the power to vote with respect to the election of members of the board of
directors) outstanding immediately after the consummation of such transaction or series of related transactions, whether such transaction involves a direct issuance from the Company or the acquisition of outstanding securities held by one or more of
the Company’s existing stockholders. 
 6. Delivery of Common Stock. The Company shall not be obligated to deliver any shares of
Common Stock to be awarded hereunder until (i) all federal and state laws and regulations as the Company may deem applicable have been complied with; (ii) the shares have been listed or authorized for listing upon official notice to the
national stock exchange on which the Common Stock is traded or have otherwise been accorded trading privileges; and (iii) all other legal matters in connection with the issuance and delivery of the shares have been approved by the
Company’s legal department. 

 7. Tax Withholding. The Participant shall be responsible for the payment of any taxes of any kind
required by any national or local law to be paid with respect to the shares of Common Stock to be awarded hereunder, including, without limitation, the payment of any applicable withholding, income, social and similar taxes or obligations. Upon the
issuance of Common Stock, the Company shall hold back from the total number of shares of Common Stock to be delivered to the Participant, and shall cause to be transferred to the Company, whole shares of Common Stock having a Fair Market Value on
the date the shares are subject to issuance of an amount as nearly as possible equal to (rounded to the next whole share) the Company’s withholding, income, social and similar tax obligations with respect to the Common Stock. In no event shall
whole shares be withheld by or delivered to the Company in satisfaction of tax withholding requirements in excess of the maximum statutory tax withholding required by law. The obligations of the Company under this Agreement and the Plan shall be
conditional upon such payment or arrangements, and the Company shall, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant. 
 8. Limits on Transferability. Until the performance conditions of this Award have been satisfied and shares of Common Stock have been issued in
accordance with the terms of this Agreement or by action of the Committee, the Award granted hereunder is not transferable and shall not be sold, transferred, assigned, pledged, gifted, hypothecated or otherwise disposed of or encumbered by the
Participant. 
 9. Miscellaneous. 
 (a) No Rights to Continued Employment. The Company’s intent to grant the shares of Common Stock hereunder shall not confer upon the Participant any right to continued employment or other association with the Company or any of
its affiliates or subsidiaries; and 

 
this Agreement shall not be construed in any way to limit the right of the Company or any of its subsidiaries or affiliates to terminate the employment or
other association of the Participant with the Company or to change the terms of such employment or association at any time. 
 (b)
Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and
enforceable to the extent permitted by law. 
 (c) Waiver. Any waiver for the benefit of the Company contained in this Agreement may
be waived, either generally or in any particular instance, by the Board of Directors of the Company. 
 (d) Binding Effect. This
Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set forth in
Section 8 of this Agreement. 
 (e) Notices. All notices required or permitted hereunder shall be in writing and deemed
effectively given upon personal delivery or five days after deposit in the United States Post Office, by registered or certified mail, postage prepaid, addressed to the other party hereto at the address shown after its signature to this Agreement,
or at such other address or addresses as either party shall designate to the other in accordance with this Section 9(e). 
 (f)
Pronouns. Whenever the context may require, any pronouns used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural, and vice versa.

 (g) Entire Agreement. This Agreement and the Plan constitute the entire agreement between the
parties and supersedes all prior agreements and understandings relating to the subject matter of this Agreement. 
 (h) Amendment.
This Agreement may be amended or modified only by a written instrument executed by both the Company and the Participant. 
 (i) Governing
Law. This Agreement shall be construed, interpreted and enforced in accordance with the internal laws of the State of New Jersey, without regard to any applicable conflict of laws. 
 (j) Participant’s Acknowledgements. The Participant acknowledges that he: (i) has read this Agreement; (ii) has been represented in
the preparation, negotiation and execution of this Agreement by legal counsel of the Participant’s own choice or has voluntarily declined to seek such counsel; (iii) understands the terms and conditions of this Agreement; and (iv) is
fully aware of the legal and binding effect of this Agreement. 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above
written. 
  

			
	 ARBINET-THEXCHANGE, INC.

		
	By:	 	  

		
	Title:	 	
		
	Address:	 	120 Albany Street
		 	Tower II, Suite 450
		 	New Brunswick, NJ 08901
	
	  

	Name	 	
		
	Address:Form of Award Letter for Stock Options

 Exhibit 10.2 
 August 21, 2006 
 NAME 
 Street 
 City    State    Zip 
  

	Re:	WESTLAKE CHEMICAL CORPORATION 

 NONQUALIFIED
STOCK OPTION AWARD 
 Dear XXXXX: 
 Westlake Chemical Corporation (the ”Company”) is pleased to notify you that you have been granted a nonqualified stock option (“Option”), effective August 21, 2006 (the “Award Date”), to
purchase 1,345 shares of common stock of the Company (“Common Stock”) in accordance with the Westlake Chemical Corporation 2004 Omnibus Incentive Plan (the “Plan”). Your award is more fully described in the attached
Appendix A, Terms and Conditions of Director Stock Option Award. 
 The price at which you may purchase the shares of Common Stock covered by the Option is
$30.07 (the “Grant Price”). Unless otherwise provided in the attached Appendix A, your Option will expire on the tenth anniversary of the Award Date (the “Expiration Date”), and will become exercisable in installments as
follows (the “Schedule”): 
  

				
	 1. Period Beginning
	  	 2. Per Cent of Shares
 Purchasable
	 
	 August 21, 2007
 August 21, 2008
 August 31, 2009
 August 21, 2010
	  	25
25
25
25	%
%
%
%

 Unless otherwise provided in the attached Appendix A, you must be in continuous service as a Director (as defined
in the Plan) with the Company from the Award Date through each date on which your Option becomes exercisable in order for your Option to become exercisable on such date. Fractional shares will be rounded for purposes of vesting in accordance with
Plan policy. 
 Your award is subject to the terms and conditions set forth in the Plan and in the Prospectus for the Plan, both of which have been
previously provided to you. Your award is also subject to any additional terms and conditions set forth in the attached Appendix A and any rules and regulations adopted by the Plan’s Administrator (as defined in the Plan). In conjunction with
this award we are also required to provide you with the most current relevant SEC filings by the Company; therefore, we refer you to the SEC Filings section of our web page, www.westlakechemical.com. 

 Page 2 
 Nonqualified Stock Option Award 
 August 21, 2006 
 This award letter and the attachment contain the formal terms and conditions of your award and
accordingly should be retained in your files for future reference. If you have any questions regarding this award, you may contact Mr. David Hansen, Sr. Vice President, Administration at 713-960-9111. 
 Very truly yours, 
 Albert Chao 
 President & Chief Executive Officer 
 Enclosure 

 Appendix A 
 to Award Letter 
 dated 
 August 21, 2006 
 Terms and Conditions of 
 Director Stock Option Award 
 The nonqualified stock
option (the “Option”) granted to you by Westlake Chemical Corporation (the ”Company”) to purchase common stock of the Company (“Common Stock”) is subject to the terms and conditions set forth in the Westlake
Chemical Corporation 2004 Omnibus Incentive Plan (the “Plan”), any rules and regulations adopted by the Administrator (as defined in the Plan), and any additional terms and conditions set forth in this Appendix A which forms a part of
the attached award letter to you (the “Award Letter”). Any terms used in this Appendix A and not defined in the Award Letter or this Appendix A have the meanings set forth in the Plan. In the event there is an inconsistency
between the terms of the Plan and this Appendix A, the terms of the Plan will control. 
  

	1.	Grant Price 

 You may purchase the shares of Common
Stock covered by the Option for the Grant Price stated in your Award Letter. 
  

	2.	Term of Option 

 Your Option expires on the
Expiration Date stated in your Award Letter. However, your Option will terminate prior to the Expiration Date as provided in Paragraph 6 of this Appendix A upon the occurrence of one of the events described in that paragraph. Regardless of the
provisions of Paragraph 6, in no event can your Option be exercised after the Expiration Date. 
  

	3.	Earn-out of Option 

  

	 	(a)	Unless it becomes vested and exercisable on an earlier date as provided in Paragraph 6 below, your Option will become vested and exercisable in cumulative installments as set forth
in the Schedule in your Award Letter. 

  

	 	(b)	To the extent your Option has become vested and exercisable, you may exercise the Option as to all or any part of the shares covered by the Option, at any time on or before the date
the Option expires or terminates, subject to any limitations imposed by law or by Company policy regarding transactions in Common Stock. 

	4.	Exercise of Option 

 Subject to the limitations set
forth in this Appendix A and in the Plan, your Option may be exercised from time to time, in accordance with its terms, by written notice signed and delivered by you or another person entitled to exercise the Option to the General Counsel of the
Company at its principal executive office in Houston, Texas, or as it may hereafter be located, as set forth below. Such written notice shall (a) state the number of shares of Common Stock with respect to which your Option is being exercised
and (b) be accompanied by a wire transfer, cashier’s check, cash, money order or other form of payment deemed acceptable by the Administrator or its designee and made payable to Westlake Chemical Corporation in the full amount of the Grant
Price for any shares of Common Stock being acquired and any appropriate withholding taxes (as provided in Paragraph 7 of this Appendix A), or by other consideration in the form and manner approved by the Administrator or its designee pursuant
to Paragraphs 5 and 7 of this Appendix A. In the alternative, the Administrator or its designee may prescribe other procedures for exercise of your Option. If any law or regulation requires the Company to take any action with respect to the
shares specified in such notice, the time for delivery thereof, which would otherwise be as promptly as possible, shall be postponed for the period of time necessary to take such action. You shall have no rights of a shareholder with respect to
shares of Common Stock subject to your Option unless and until such time as your Option has been exercised and ownership of such shares of Common Stock has been transferred to you. 
  

	5.	Satisfaction of Grant Price 

  

	 	(a)	Payment of Cash or Common Stock. Your Option may be exercised by payment in cash (including check, bank draft, money order or wire transfer payable to the Company), in Common
Stock, in a combination of cash and Common Stock or in such other manner as the Administrator in its discretion may provide. 

  

	 	(b)	Payment of Common Stock. The Fair Market Value of any shares of Common Stock tendered as all or part of the Grant Price shall be determined as provided in the Plan. The
certificates evidencing shares of Common Stock tendered must be duly endorsed or accompanied by appropriate stock powers. Only stock certificates issued solely in your name may be tendered in exercise of your Option. Fractional shares may not be
tendered in satisfaction of the Grant Price; any portion of the Grant Price which is in excess of the aggregate Fair Market Value of the number of whole shares tendered must be paid in cash. If a certificate tendered in exercise of the Option
evidences more shares than are required pursuant to the immediately preceding sentence for satisfaction of the portion of the Grant Price being paid in Common Stock, an appropriate replacement certificate will be issued to you for the number of
excess shares. 

	 	(c)	Broker-Assisted Exercise. At your request or the request of another person entitled to exercise this Option, and to the extent permitted by applicable law, the Administrator
in its discretion may selectively approve “cashless exercise” arrangements with a brokerage firm under which such brokerage firm, on behalf of you or such other person exercising the Option, shall pay to the Company or its designee the
Grant Price of the Option or of the portion being exercised, and the Company or its designee, pursuant to an irrevocable notice from you or such other person exercising the Option, shall promptly deliver the shares being purchased to such firm.

  

	6.	Termination of Service 

  

	 	(a)	General. The following rules apply to your Option in the event of your death, disability or other termination of service as a Director. 

 (i) Death or Disability. If your service terminates by reason of death or disability, your Option will become fully vested and exercisable and will
remain exercisable until the first to occur of (A) in the event of your termination due to disability, 180 days after the date of your termination, (B) in the event of your termination due to death, one year after the date of your death or
(C) the Expiration Date. 
 (ii) Failure to be Re-Elected or Re-nominated; Termination at the Request of the Board of Directors.
If your service is terminated because (A) you fail to be re-elected or re-nominated for service as a Director for any reason other than cause (as determined by the Administrator) or (B) you resign as a Director at the request of the Board
of Directors based upon a determination made by the Board of Directors, in its sole discretion, that your resignation would be in the best interests of the Company, your Option will become fully vested and exercisable and will remain exercisable
until the first to occur of (X) 30 days following your last day in the capacity of a Director, or (Y) the Expiration Date. 
 (iii)
Other Termination of Service. If your service as a Director terminates for any reason other than those provided in clauses (i) and (ii) above, your Option will terminate 30 days after your termination of service. Following the
termination of your service, no additional portions of your Option will become vested and exercisable, and your Option will be limited to the number of shares of Common Stock which you were entitled to purchase under the Option on the date of the
termination of your service. 
 (iv) Adjustments by the Administrator. The Administrator may, in its sole discretion, exercised before
or after your termination of service, declare all or any portion of your Option immediately vested and exercisable and/or permit all or any part of your Option to remain exercisable for such period designated by it after the time when the Option
would have otherwise terminated as provided in the applicable portion of this Paragraph 6(a), but not beyond the Expiration Date of your Option. 

	 	(b)	Administrator Determinations. The Administrator shall have absolute discretion to determine the date and circumstances of termination of your service, and its determination
shall be final, conclusive and binding upon you. 

  

	7.	Restrictions on Resale 

 There are no restrictions
imposed by the Plan on the resale of shares of Common Stock acquired under the Plan. However, under the provisions of the Securities Act of 1933 (the ”Securities Act”) and the rules and regulations of the Securities and Exchange
Commission (the “SEC”), resales of shares acquired under the Plan by certain officers and directors of the Company who may be deemed to be “affiliates” of the Company must be made pursuant to an appropriate effective registration
statement filed with the SEC, pursuant to the provisions of Rule 144 issued under the Securities Act, or pursuant to another exemption from registration provided in the Securities Act. At the present time, the Company does not have a currently
effective registration statement pursuant to which such resales may be made by affiliates. There are no restrictions imposed by the SEC on the resale of shares acquired under the Plan by persons who are not affiliates of the Company. However, the
timing of sales of shares may be restricted by applicable law, and the Company may, from time to time, adopt policies regarding timing of sales of shares by employees. 
 If you have any questions regarding your Option or would like to obtain additional information about the Plan or the Administrator, please contact the Senior Vice President, Administration or the General Counsel of
the Company, Westlake Chemical Corporation, 2801 Post Oak Boulevard, Suite 600, Houston, Texas 77056 (telephone (713) 960-9111). Your Award Letter and this Appendix A contain the formal terms and conditions of your award and accordingly
should be retained in your files for future reference.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}]]